Kaiku Health, together with Oulu University Hospital and Vaasa Central Hospital, presents research at the virtual ESMO Congress 2021. The research investigates how ePRO follow-up affects patient care of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy. According to the results, ePRO follow-up was found to be good with 98% of the patients suggesting that the...
Kaiku Health adds more expertise in life sciences and international business development to the leadership team by welcoming Katariina Kronholm as the new Chief Commercial Officer. Katariina has over a decade of experience helping senior leaders design and deliver complex business transformations across multiple geographies with a focus on life sciences and healthcare. As a...
New research by Kaiku Health, Docrates Cancer Center, and Hirslanden Institut für Radiotherapie Aarau will be presented at ESTRO 2021 as a poster discussion. This year, the congress is organized as a hybrid event and the poster session takes place online. Presented by Juha Kononen from Docrates Cancer Center, the poster shares insights into the...
Deep learning systems have widely presented promising results in cancer diagnostics [1] and for Kaiku Health, machine learning (ML) based approaches are not anything new. Previously, Oulu University Hospital (OYS) and Kaiku Health have shown that it is possible to predict both symptom and adverse event onset and continuation in patients receiving immune checkpoint inhibitor...
Kaiku Health, the developer of digital health intervention platform in oncology, today announced it will develop digital patient monitoring and management for melanoma patients in collaboration with Novartis, a leading global medicines company. Melanoma is less common than other types of skin cancer, but it can more easily spread to other parts of the body....